Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Man Group’s FRM says hedge funds suffer losses in April as managers were caught on the wrong side

Thursday, May 15, 2014

Komfie Manalo, Opalesque Asia:

Hedge funds suffered their second successive negative month in April as many managers were caught on the wrong side of the market movement, said Man Group’s $16.7bn fund of hedge funds FRM. FRM is a top global industry allocator to hedge funds by AUM, and the largest independent European based FoHF managing commingled funds and advising clients.

In its Early View report, FRM said hedge fund losses in April were heavily concentrated in Equity Long-Short strategies. "The rotation amongst sectors and from growth to value in the U.S. continued in April. Many managers were caught on the wrong side of the move and suffered large losses," the report said. It added, "In Europe, there was a clear relationship between the performance of commonly held positions in the US and the subsequent days trading in European stocks. Equity Long-Short managers have generated very strong performance over the last year."

According to FRM, Event Driven managers posted muted gains in April as special situations trading detracted from performance while traditional merger arbitrage contributed positively.

Credit based strategies were unaffected for the second month in a row by the technical issues facing equity based strategies, it said, while managed futures managers were flat, which was a substantial recovery from th......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its